Security key
3622AW403
GRI Bio, Inc. - Common stock, par value $0.0001 per share (GRI)
CUSIP: 3622AW403
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common stock, par value $0.0001 per share
- Total 13F shares
- 134,385
- Total 13F value
- $276,832
- Share change
- +114,749
- SEC-reported price per share
- $2.06
- Number of holders
- 8
- Value change
- +$236,163
- Number of buys
- 5
- Number of sells
- 1
- Shares outstanding
- 1,533,475
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
8
Top holders
8
GRI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
GRI Bio, Inc. SEC filings
GRI Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 3622AW403
Recent filing periods:
Ownership snapshot
Top reported holders of GRI - GRI Bio, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Albert Agro
Disclosed value leader
Albert Agro
Comparable rows
0/15
Latest evidence
18 Sep 2025
3/4/5
13F
Highest disclosed value: $702,531
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Albert Agro has the largest disclosed position value at $702.5K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Albert Agro's linked filing trail.
Disclosed position value
Top 5
Albert Agro
$702.5K
Walter Marc Hertz
$89K
Marella Thorell
$38.8K
Leanne Kelly
$29.7K
Vipin Chaturvedi
$29.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Albert Agro |
3/4/5
Chief Medical Officer
|
—
denominator unverified
|
$702,531
172,189 shares
|
— | 21 Apr 2023 |
| Walter Marc Hertz |
3/4/5
Chief Executive Officer, Director
|
—
denominator unverified
|
$88,956
103,067 shares
|
— | 18 Sep 2025 |
| Marella Thorell |
3/4/5
Director
|
—
denominator unverified
|
$38,784
9,506 shares
|
— | 13 Dec 2022 |
| Leanne Kelly |
3/4/5
Chief Financial Officer
|
—
denominator unverified
|
$29,704
43,222 shares
|
— | 18 Sep 2025 |
| Vipin Chaturvedi |
3/4/5
Chief Scientific Officer
|
—
denominator unverified
|
$29,704
43,222 shares
|
— | 18 Sep 2025 |
| Ofir Levi |
3/4/5
Director
|
—
denominator unverified
|
$20,571
30,000 shares
|
— | 14 May 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
134,385
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q4 2025 Across Filers
Q4 2025 holders
6
Q3 2025 holders
8
Holder diff
2
| Investor | Q4 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend